CMS Open Payments · Program Year 2024
Outset Medical Inc
Outset Medical Inc reported $160,738.29 across General Payments, Research, and Ownership to 340 physicians and teaching hospitals across 340 transactions.
- $160.7K Below-median payer
- All-tracks total
- 340 Above-median volume
- Transactions
- 340 Above-median reach
- Recipients
- −$432.5K
- General Payments vs PY2023
Outset Medical Inc reported $160,738.29 across all CMS Open Payments tracks (General + Research + Ownership) to 340 physicians and teaching hospitals in Program Year 2024 - ranking #1069 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $160,738.29, averaging $472.76 per recipient.
How Outset Medical Inc's $160.7K all-tracks total breaks down
Outset Medical Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
25/100
Total payments
F
11/100
Transaction volume
F
12/100
Physician reach
F
13/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer outset-medical-inc Outset Medical Inc
$160.7K · #1069/1,925 · 0.0% industry · PY2024
- TOT $160.7K
- RANK #1069
- SHARE 0.0%
- TXN 340
- RCP 340
- CAT 5
- GEN $160.7K
- ΔGEN −$432.5K
- TOP1 28.9%
- PY 2024
Volume peers
Nearest volume peer: Erbe USA Inc ($161.0K)
Outset Medical Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Outset Medical Inc's CMS-reported General Payments decreased by $432.5K (−72.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: OUTSET MEDICAL INCPY2023: OUTSET MEDICAL INCPY2024: Outset Medical Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $593,199.47
- PY2024
- $160,738.29
What the Data Shows for Outset Medical Inc
The all-tracks total above combines three CMS reporting categories - General Payments, Research Payments, and Ownership/Investment interests - not one undifferentiated figure. For Outset Medical Inc, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS publishes each Program Year's data roughly 12 months after the reporting period ends, so this reflects the most recently released cycle; see our methodology for how the tracks are standardized and compared across companies.
10 transactions worth $75.2K make "Consulting Fee" the top general-payment category in the 5-category breakdown below, 46.8% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Across 5 types of general payments, Outset Medical Inc's largest category was "Consulting Fee" at $75.2K - 46.8% of General Payments.
Outset Medical Inc reports 5 general-payment categories - the top three are Consulting Fee (46.8%), Honoraria (24.3%), and Compensation for Services Other Than Consulting (12.6%). The remaining 2 categories make up 16.2% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Outset Medical Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $75.2K | 10 | 46.8% |
| Honoraria | $39.1K | 19 | 24.3% |
| Compensation for Services Other Than Consulting | $20.3K | 15 | 12.6% |
| Food and Beverage | $18.4K | 261 | 11.5% |
| Travel and Lodging | $7.7K | 35 | 4.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $117,162.06 (72.9%) of $160,738.29 in this company's General Payments records across 205 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Outset Medical Inc
The five named recipients with the highest reported General Payments from this company
- 1
Glenn Matthew Chertow
$46,500.00 across 2 reported transactions
- 2
Geoffrey Block
$28,382.50 across 7 reported transactions
- 3
Sevag Garabet Demirjian
$17,309.84 across 15 reported transactions
- 4
Luke Basdeo
$13,077.99 across 15 reported transactions
- 5
Luis Alvarez
$11,891.73 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Outset Medical Inc's spend rank (#1069 of 1,925, bottom 45% by spend) and concentration rank (#887 of 1,838, top 48% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Sequel Med Tech, LLC : $5.1K total payments, HHI 1455
- United Imaging Healthcare North America LLC : $51.7K total payments, HHI 1453
- Qapel Medical Inc : $256.6K total payments, HHI 1446
- CMS Imaging, Inc. : $44.5K total payments, HHI 1444
- Hu-Friedy Mfg. Co., LLC : $554.1K total payments, HHI 1438
- Elevate Oral Care : $47.1K total payments, HHI 1437
- Outset Medical Inc (this company) : $160.7K total payments, HHI 1433
- Total Joint Orthopedics, Inc. : $245.5K total payments, HHI 1433
- Great Lakes Medical Services, LLC : $5.8K total payments, HHI 1429
- Virtual Incision Corporation : $447.4K total payments, HHI 1423
- Aadi Bioscience, Inc. : $255.4K total payments, HHI 1423
- Empire Medical, Inc : $4.0K total payments, HHI 1422
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Outset Medical Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Outset Medical Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Outset Medical Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Serpex Medical Inc
Olea Medical
Garrison Dental Solutions
Micro-tech Endoscopy USA, Inc.
NX Development Corp.
Put this to use
Outset Medical Inc ranks #1069 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Outset Medical Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.